摘要
目的 研究异基因造血干细胞移植(allo-HSCT)后患者外周血CD4^+CD25^High调节性T细胞(Treg细胞)及细胞因子白细胞介素-10(IL-10)与急性移植物抗宿主病(aGVHD)的关系.方法 采用流式细胞术检测13例allo-HSCT后患者外周血CD4^+CD25^HighFoxp3^HghTreg细胞、CD4^+CD25^HighCD^127LowTreg细胞占CD^4+T细胞的百分含量,同时用酶联免疫吸附法(ELISA)检测对应时期血清中IL-10的质量浓度.结果 13例患者均获得造血功能重建;aGVHD组CD4^+CD25^HighCD127^Low/CD4^+与CD4^+CD25^HighFoxp3^High/CD4^+比例均明显低于无GVHD组,差异有统计学意义(P<0.01);Ⅲ~Ⅳ度aGVHD亚组CD4^+CD25^HighCD^127Low/CD4^+与CD4^+CD25^HighFoxp^3High/CD4^+比例低于Ⅰ~Ⅱ度aGVHD亚组,但差异无统计学意义(P>0.05);相同组别间CD4^+CD25^HighCD^127Low/CD4^+与CD4^+CD25^HighFoxp^3High/CD4^+差异无统计学意义.aGVHD组的IL-10质量浓度明显低于无GVHD组,差异有统计学意义(P<0.01).Treg细胞与IL-10变化呈相关性(r=0.925,P<0.05).结论 Treg细胞的水平与allo-HSCT后aGVHD的发生有密切关系;通过监测Treg细胞水平对临床早期诊断aGVHD及判断aGVHD预后、指导免疫调节剂的应用具有重要意义;CD127^Low可以作为Treg细胞表面的特异标志,推进对Treg细胞的检测及分离纯化;IL-10是一种重要的负调控因子;Treg细胞与IL-10的表达在aGVHD患者存在相关性,可能为Treg细胞的免疫抑制机制提供一定基础.
Objective To investigate the relationship between the CD4^+CD25^High regulatory T cells and cytokine IL-10 and acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods Flow cytometric was used to detect the percentage of CD4^+CD25^High Foxp^3Hiht Treg cell and CD4^+CD25^HighCD^127LowTreg cell in CD4^+ T cells and at the same time ELISA was used to test the serum IL-10 levels in corresponding period. Results 13 patients have received hcmatopoietic function reconstruction, aGVHD group of CD4^+CD25^HighCD127^Low/CD25^HighFoxp3^High/CD4^+ ratio were significantly lower than non-aGVHD group, the difference was statistically significant (P 〈0.01); Ⅲ~Ⅳ degree of aGVHD subgroup was lower than Ⅰ~Ⅱ degree of aGVHD subgroup, but no statistical significance(P 〉0.05); the same as between-group CD4^+CD25^HighCD127^Low/CD4^+ and the CD4^+CD25^HighFoxp3^High/CD4^+ has no significant difference; aGVHD group of IL-10 concentration was significantly lower than non-GVHD group, the difference was statistically significant (P 〈0.01). Treg cell and IL-10 changes in correlation, r = 0.557, P 〈0.05. Conclusion The level of Treg cell was closely related to the occurrence of aGVHD after allo-HSCT. So it is very important to monitor the Treg cell level for clinical carly diagnosis of aCVHD and predict prognosis of aGVHD and guide the application of immunosuppressant. CD127 can serve as a Treg cell surface-specific marker, to promote the detection of Treg cell and purification. IL-10 was an important negative regulator. Treg cell and IL-10 expression in patients with aGVHD was correlation, which may provide some basis for Treg cell immunosuppressive mechanism.
出处
《白血病.淋巴瘤》
CAS
2010年第9期536-538,547,共4页
Journal of Leukemia & Lymphoma